Tumor recurrence remains to be an obstacle after liver organ medical

Tumor recurrence remains to be an obstacle after liver organ medical operation especially in living donor liver organ transplantation (LDLT) for sufferers with hepatocellular carcinoma (HCC). in small-for-size group was considerably greater than that entirely graft group at time 1 (251 ± 53 pg/ml 119 ± 10 pg/ml = 0.013) and time 7 (251 ±… Continue reading Tumor recurrence remains to be an obstacle after liver organ medical